Analysts who follow Aslan Pharmaceuticals Ltd (ASLN) on average expect it to rise 266.67% over the next twelve months. Those same analysts give the stock an average rating of Strong Buy.
That average rating earns Aslan Pharmaceuticals Ltd an Analyst Ranking of 80, which means it ranks higher than 80 of stocks, based on data compiled by InvestorsObserver.
Why are Analyst Ratings Important?
Analysts know the inner workings of the companies they follow better than anyone but the companies’ management. You can learn a lot about a company from studying the financial statements, but analysts ask questions on conference calls and understand the intricacies of each of the businesses they cover. Analysts understand how bad weather in one part of the world can disrupt supply chains, or disrupt shopping patterns. This lets traders make decisions before a quarterly report that could be worse than expected.
InvestorsObserver aggregates the ratings of all the analysts covering a given stock, takes the average of those ratings and then percentile ranks the averages. That provides a level of granularity that is significantly better than just the three levels provided by traditional buy/hold/sell ratings.
What's Happening With Aslan Pharmaceuticals Ltd Stock Today?
Aslan Pharmaceuticals Ltd (ASLN) stock is trading at $1.50 as of 3:26 PM on Wednesday, Sep 2, an increase of $0.02, or 1.35% from the previous closing price of $1.48. Volume today is above average. So far 112,659 shares have traded compared to average volume of 61,940 shares. The stock has traded between $1.30 and $1.50 so far today.
Click Here to get the full report on Aslan Pharmaceuticals Ltd (ASLN) Stock.
